Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorChinese University of Hong Kong

About this trial

Background Reperfusion therapies, i.e., intravenous thrombolysis (IVT) and/or endovascular thrombectomy (EVT), are most effective treatments in the management of acute ischemic stroke (AIS) patients. The benefits of reperfusion therapies, however, may be reduced by treatment delays due to tests and examinations and logistic issues. Emergency Stroke Unit (ESU), a new concept of stroke unit locating at the Accident and Emergency Department (AED), equipped with a mobile, low-field MR imaging (lfMRI) scanner for fast diagnosis of ischemic stroke, differentiation of intracranial hemorrhage and identification of large vessel occlusion (LVO), is being tested in Mainland China. It may shorten the door-to-needle time (DNT) for IVT and door-to-groin puncture time (DPT) for EVT, which may hance associate with improved functional outcomes of AIS patients.

This is a prospective, single-center, open-label, non-randomized, single-arm study aims to evaluate the safety and efficacy of the ESU workflow using lfMRI in shortening the DNT/DPT and improving functional outcomes in AIS patients, who are eligible for IVT and/or EVT and can be treated within 6 hours after onset, compared with standard practice in Hong Kong; to reveal the changes in the ischemic lesions over a few days after IVT/EVT in these patients, with serial follow-up lfMRI exams.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years;

Diagnosed as ischemic stroke;

Eligible for IVT and/or EVT and can be treated within 6 hours of symptom onset (time of symptom onset is defined as the last known normal time);

Presenting to AED during working hours (8AM to 6PM, weekdays);

Disqualifiers

Patients with unstable vital signs who need urgent medical interventions/care;

Confirmed contraindications for IVT or EVT by initial assessment (e.g., unstable vital signs, history of severe head trauma within 3 months, known bleeding tendency), before starting brain imaging exams;

Claustrophobia or other conditions that are contraindicated for MRI;

Patients with pacemakers, brain stimulators or insulin pumps;

Trial design

Design model

Single group

Treatments tested in this trial

  • Portable Magnetic Resonance Imaging

    Device

    0.23T Low-field Magnetic Resonance Imaging

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Acute ischemic stroke patients , eligible for IVT and/or EVTExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Door-to-Needle time(min) for intravenous thrombolysis

Reduction in the Door-to-Needle time(min) for intravenous thrombolysis

Time frame
Day 0

Secondary outcomes

1

Door-to-Groin Puncture time (min) for endovascular thrombectomy (EVT)

Reduction in the Door-to-Groin Puncture time (min) for endovascular thrombectomy

Time frame
Day 0
2

Time from symptom onset to decision for IVT/EVT (min)

Reduction in time from symptom onset to decision for IVT/EVT (min)

Time frame
Day 0
3

Time from admission to decision for IVT/EVT (min)

Reduction in time from admission to decision for IVT/EVT (min)

Time frame
Day 0
4

Improvement in NIHSS score at 24 hours compared to baseline

30% improvement in NIHSS score at 24 hours compared to baseline

Time frame
From Day 0, post treatment, to Day 1.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chinese University of Hong Kong

Lead sponsor

Beijing Tiantan Hospital

Collaborator